Table 5:
Crude and adjusted hazard ratios (HRs) for incident atrial fibrillation, by level of alcohol consumption*
Alcohol consumption | % (no.) of patients with incident atrial fibrillation | HR (95% CI) | ||||
---|---|---|---|---|---|---|
Unadjusted analysis | Model 1† | Model 2‡ | Model 3§ | Model 4¶ | ||
Low | 6.3 (1 179/18 775) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Moderate | 7.8 (871/11 139) | 1.23 (1.12–1.34) | 1.15 (1.05–1.26) | 1.16 (1.06–1.28) | 1.14 (1.04–1.26) | 1.14 (1.04–1.26) |
High | 8.3 (43/519) | 1.31 (0.97–1.78) | 1.29 (0.95–1.76) | 1.34 (0.99–1.83) | 1.32 (0.97–1.80) | 1.32 (0.97–1.80) |
p value for trend | < 0.001 | 0.001 | < 0.001 | 0.002 | 0.002 |
Note: CI = confidence interval, ref = reference category.
Low = < 1 drink/wk; moderate = 1–14 drinks/wk (about 2 drinks/d) for women and 1–21 drinks/wk (about 3 drinks/d) for men; high = > 14 drinks/wk (> 2 drinks/d) for women and > 21 drinks/wk (> 3 drinks/d) for men.
Model 1: Adjusted for age, sex, body mass index and region (Europe or Americas v. Australia/Asia).
Model 2: Adjusted for covariates in model 1, plus medical history of coronary artery disease, stroke or transient ischemic attack, hypertension, diabetes, chronic renal disease, and sleep apnea.
Model 3: Adjusted for covariates in model 2, plus smoking status, education (1–8 yr, 9–12 yr or college/trade v. none), physical activity (2–4 times/wk or ≥ 5 times/wk v. < 1 time/wk) and stress.
Model 4: Adjusted for covariates in model 3, plus use of statin and treatment allocation (ramipril, telmisartan or both v. placebo) in the trials.